Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems
Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy.
FDA shares warning about cath lab procedure kits due to risk of patient injury
The syringes included in several convenience kits commonly used by interventional cardiologists and interventional radiologists should not be used. If treatment is necessary and no other devices are available, it should be done with “extreme caution and vigilance.”
New data highlight an unexpected link between hypercortisolism and resistant hypertension
Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension.
FDA clears new AI model for detecting signs of cardiac amyloidosis
This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.
PVL after TTVR linked to much lower survival rate, fewer clinical benefits
TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems

Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy.

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits commonly used by interventional cardiologists and interventional radiologists should not be used. If treatment is necessary and no other devices are available, it should be done with “extreme caution and vigilance.”

Deepak Bhatt discusses the MOMENTUM STUDY and the prevalence of hypercortisolism hypertension. #ACC #ACC26

New data highlight an unexpected link between hypercortisolism and resistant hypertension

Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension.

artificial intelligence AI heart cardiology

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.

Edwards Evoque transcatheter tricuspid valve replacement TTVR

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explains the goals of the SVS quality assessment program.

SVS quality initiative gathers data to improve vascular care

More than 7,000 physicians from a wide variety of healthcare specialties are already participating in the project.

Former Amazon One Medical doctor alleges she was fired for reporting patient safety issues

Sue Kim, MD, a primary care provider who worked for One Medical for more than a decade, claims in a lawsuit that she was fired for reporting patient safety incidents to a supervisor, which spurred the company to launch a targeted investigation designed to discredit her. Amazon, the parent company of One Medical, disputes Kim’s story.

Post-TAVR bleeding in AFib patients much less common with apixaban than rivaroxaban

When it came to all-cause mortality and ischemic stroke, however, the two popular DOACs were associated with comparable outcomes.